IL-5RA/CD125 Recombinant antibody

IL-5RA/CD125 Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 84948-5-RR

产品说明书

CloneNo. 242234H8

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

WB, ELISA

IL5RA, IL 5R subunit alpha, IL 5R alpha, IL 5 receptor subunit alpha, HSIL5R3

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inhuman peripheral blood platelets

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

84948-5-RR targets IL-5RA/CD125 in WB, ELISA applications and shows reactivity with human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human
免疫原 Recombinant protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 interleukin 5 receptor, alpha
别名 IL5RA, IL 5R subunit alpha, IL 5R alpha, IL 5 receptor subunit alpha, HSIL5R3
计算分子量48 kDa
观测分子量60 kDa
GenBank蛋白编号NM_175726.4
基因名称 IL-5RA
Gene ID (NCBI) 3568
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ01344-1
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Interleukin-5 receptor subunit alpha (IL-5RA), also known as CD125, is a type I transmembrane protein that belongs to the type I cytokine receptor family. IL-5RA is a critical component of the high-affinity IL-5 receptor complex, IL-5R, which consists of the alpha chain (IL-5RA) that specifically binds to IL-5 and the common beta chain (CD131) shared with receptors for IL-3 and GM-CSF (PMID: 1833065; 7872157). IL-5/IL-5RA signaling axis is crucial for the differentiation, proliferation, recruitment, and activation of eosinophils, and is also involved in pathological eosinophilia (PMID: 34638583).

实验方案

Product Specific Protocols
WB protocol for IL-5RA/CD125 antibody 84948-5-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...